Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 4:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 889–912 of 1,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ulcerative Clear all

Conditions: Colitis, Ulcerative
Interventions: Spesolimab, Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 13
States / cities: Hamden, Connecticut • Miami, Florida • Orlando, Florida + 10 more

Conditions: Diabetic Foot Ulcer
Interventions: Standard of Care, Nitric Oxide Therapy 2x week 6 min. plus standard of care, Nitric Oxide Therapy 2x week 12 min. plus standard of care, Nitric Oxide Therapy 4x week 6 min. plus standard of care, Nitric Oxide Therapy 4x week 12 min. plus standard of care; Device
Lead sponsor: Origin Inc.; Industry
Eligibility: 22 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 15
States / cities: Montgomery, Alabama • Phoenix, Arizona • Tucson, Arizona + 11 more

Conditions: Lower Extremity Chronic Ulcers in Diabetics, Diabetic Foot Ulcer (DFU)
Interventions: amniotic membrane; Other
Lead sponsor: Tides Medical; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 5
States / cities: North Port, Florida • Buffalo, New York • Monroeville, Pennsylvania + 2 more

Conditions: Infections, Gram-Positive Bacterial, Abscess, Burns, Cellulitis, Ulcer, Wound Infections
Interventions: Telavancin, Vancomycin or antistaphylococcal penicillin; Drug
Lead sponsor: Cumberland Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 169 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: Crohn's, Ulcerative Colitis, Gastrointestinal Bleeding
Interventions: Linaclotide; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Helicobacter Infections, Gastritis, Peptic Ulcer
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 6 Months to 18 Years
Enrollment: 755 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2007
U.S. locations: 3
States / cities: Miami, Florida • Atlanta, Georgia • Cleveland, Ohio

Conditions: Pressure Ulcer
Interventions: 2 hour repositioning, 3 hour repositioning, 4 hour repositioning; Other
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 2,113 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Wallingford, Connecticut

Conditions: Gastric Ulcer
Interventions: Esomeprazole Sodium; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 5
States / cities: Newark, Delaware • Shreveport, Louisiana • Hershey, Pennsylvania + 2 more

Conditions: Wounds and Injuries, Wound Healing, Ulcer
Interventions: Not listed
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 18 Years to 40 Years · Male only
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetic Foot Ulcers
Interventions: Affinity Allograft, Standard of care; Other
Lead sponsor: Organogenesis; Industry
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 8
States / cities: Miami Lakes, Florida • North Miami Beach, Florida • Clinton Township, Michigan + 5 more

Conditions: Inflammatory Bowel Diseases, IBD, Crohn Disease, Ulcerative Colitis
Interventions: SMART-IBD; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 13 Years to 17 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Pressure Ulcers
Interventions: Nutritional Supplement/Amino acids and HMB, Juven; Dietary Supplement
Lead sponsor: Central Arkansas Veterans Healthcare System; Federal
Eligibility: 21 Years to 90 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Diabetic Foot Ulcers
Interventions: acoustical pulse energy (extracorporeal shockwave), Sham; Device · Other
Lead sponsor: SANUWAVE, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 21
States / cities: Phoenix, Arizona • Tucson, Arizona • Castro Valley, California + 16 more

Conditions: Pressure Ulcers
Interventions: TheraHoney HD, SkinTegrity; Device
Lead sponsor: Medline Industries; Industry
Eligibility: Not listed
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Wound Healing
Interventions: Procellera™ Wound Dressing with V.A.C.® Therapy, V.A.C.® Therapy; Device
Lead sponsor: Vomaris Innovations; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Venous Reflux
Interventions: VenaSeal™ System, Endothermal Ablation (ETA), Surgical Stripping; Device · Procedure
Lead sponsor: Medtronic Endovascular; Industry
Eligibility: 18 Years and older
Enrollment: 506 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 12
States / cities: Prescott Valley, Arizona • Tucson, Arizona • Fresno, California + 9 more

Conditions: Colitis, Ulcerative
Interventions: Etrolizumab, Placebo; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 359 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 33
States / cities: Orange, California • San Diego, California • San Francisco, California + 29 more

Conditions: Pressure Ulcers
Interventions: Quantum Negative Pressure Wound Therapy Device; Device
Lead sponsor: Innovative Therapies, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Foot Ulcer, Diabetic
Interventions: Transcutaneous O2 device; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Patient Positioning, Monitoring, Physiologic, Pressure Ulcer
Interventions: Zephyr BioPatch; Device
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Ulcerative Colitis
Interventions: Freeze-dried black raspberry powder; Drug
Lead sponsor: UConn Health; Other
Eligibility: 18 Years to 90 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Colitis, Ulcerative
Interventions: JNJ-77242113, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 32
States / cities: Anaheim, California • Newport Beach, California • San Diego, California + 28 more

Conditions: Diabetic Foot Ulcers
Interventions: Santyl, Tegaderm Hydrogel; Drug
Lead sponsor: Healthpoint; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Zollinger Ellison Syndrome
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1989 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis

A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers

Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.

Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

Single-dose Linaclotide for Capsule Endoscopy Preparation

Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)

Preventing Pressure Ulcers With Repositioning Frequency and Precipitating Factors

An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium

The Molecular Anatomy of Oral Wound Healing

Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers

SMART-IBD App Trial

Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB)

Effectiveness of dermaPACE™ Device and Standard Treatment Compared to Standard Treatment Alone for Diabetic Foot Ulcers

Wound Management for Sacral Pressure Ulcers With Necrotic Tissue

Efficacy Study of a Bioelectric Dressing Used With Negative Pressure Wound Therapy to Treat Diabetic and Pressure Ulcers

VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial

A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers.

Continuous Diffusion of Oxygen (CDO) Treatment for Healing of Diabetic Foot Ulcers

An Assessment of the Zephyr BioPatch and Its Ability to Monitor Patient Position

Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis

A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers

Treatment of Zollinger-Ellison Syndrome